These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15790166)

  • 21. [The SBU revises its view on estrogen replacement therapy in climacteric. Evidently increased risk of thrombosis and breast cancer].
    Hovelius B
    Lakartidningen; 2002 Jul; 99(28-29):3014-5. PubMed ID: 12170508
    [No Abstract]   [Full Text] [Related]  

  • 22. Incidence of venous thromboembolism in users of combined oral contraceptives. Risk is particularly high with first use of oral contraceptives.
    Vandenbrouke JP; Bloemenkamp KW; Rosendaal FR; Helmerhorst FM
    BMJ; 2000 Jan; 320(7226):57-8. PubMed ID: 10671043
    [No Abstract]   [Full Text] [Related]  

  • 23. Letter by Micheletti and Chevallier regarding article, "Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER Study".
    Micheletti MC; Chevallier T
    Circulation; 2007 Sep; 116(13):e362; author reply e363. PubMed ID: 17893283
    [No Abstract]   [Full Text] [Related]  

  • 24. Antipsychotic drugs and venous thromboembolism.
    Wolstein J; Grohmann R; Rüther E; Hippius H
    Lancet; 2000 Jul; 356(9225):252. PubMed ID: 10963225
    [No Abstract]   [Full Text] [Related]  

  • 25. Statins and the risk of idiopathic venous thromboembolism.
    Ray JG; Mamdani MM
    Br J Clin Pharmacol; 2003 Oct; 56(4):460; author reply 461-2. PubMed ID: 12968995
    [No Abstract]   [Full Text] [Related]  

  • 26. Incidence of venous thromboembolism in users of combined oral contraceptives. Methods for identifying cases and estimating person time at risk must be detailed.
    Jick H
    BMJ; 2000 Jan; 320(7226):57; author reply 57-8. PubMed ID: 10617543
    [No Abstract]   [Full Text] [Related]  

  • 27. C-reactive protein, idiopathic venous thromboembolism and hormone replacement therapy.
    Lowe G; Rumley A; Woodward M; Vessey M
    Thromb Haemost; 2000 Oct; 84(4):730-1. PubMed ID: 11057882
    [No Abstract]   [Full Text] [Related]  

  • 28. Hormone therapy and thromboembolic disease.
    Battaglioli T; Martinelli I
    Curr Opin Hematol; 2007 Sep; 14(5):488-93. PubMed ID: 17934355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormones and pregnancy: thromboembolic risks for women.
    Kujovich JL
    Br J Haematol; 2004 Aug; 126(4):443-54. PubMed ID: 15287937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Risk of venous thromboembolism among users of third-generation oral contraceptives].
    Vallée JP
    Presse Med; 2001 Mar; 30(11):535-6. PubMed ID: 11317930
    [No Abstract]   [Full Text] [Related]  

  • 31. [Third-generation oral contraceptives--how big is the risk of venous thrombosis?].
    Iversen OE
    Tidsskr Nor Laegeforen; 2004 Jun; 124(11):1521-2. PubMed ID: 15195157
    [No Abstract]   [Full Text] [Related]  

  • 32. Antipsychotic and antidepressant drug use in the elderly and the risk of venous thromboembolism.
    Ray JG; Mamdani MM; Yeo EL
    Thromb Haemost; 2002 Aug; 88(2):205-9. PubMed ID: 12195690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Greater saphenous vein thrombosis and testosterone replacement therapy: an occasional association?].
    Bertola G; Bianchi R; Giambona S; Sada S; Berra SA
    Recenti Prog Med; 2017 May; 108(5):239-241. PubMed ID: 28643815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thromboembolism during hormone therapy in Japanese women.
    Adachi T; Sakamoto S
    Semin Thromb Hemost; 2005 Jun; 31(3):272-80. PubMed ID: 16052396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pregnancy, contraception and HRT and venous thromboembolism].
    Conard J; Gompel A
    Rev Prat; 2007 Apr; 57(7):759-66. PubMed ID: 17626321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of venous thromboembolism in megestrol acetate users.
    Thomas DR
    J Am Med Dir Assoc; 2004; 5(1):65-6; author reply 66-7. PubMed ID: 14726802
    [No Abstract]   [Full Text] [Related]  

  • 37. How do you decide on hormone replacement therapy in women with risk of venous thromboembolism?
    Lekovic D; Miljic P; Dmitrovic A; Thachil J
    Blood Rev; 2017 May; 31(3):151-157. PubMed ID: 27998619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using case-control studies for prescribing research.
    Mant J; Vessey M
    J Clin Pharm Ther; 2002 Feb; 27(1):67-74. PubMed ID: 11846863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormonal contraception and venous thromboembolic risk in midlife women.
    Lidegaard Ø
    Maturitas; 2013 Jan; 74(1):1-2. PubMed ID: 23098858
    [No Abstract]   [Full Text] [Related]  

  • 40. Mechanisms of hormonal therapy related thrombosis.
    Sandset PM
    Thromb Res; 2013 Jan; 131 Suppl 1():S4-7. PubMed ID: 23452740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.